Computational Biology
Computational Biology is the newest of the department's four tracks for graduate education
                        and research. There are two faculty, David Green and Rob Rizzo who are biological
                        sciences PhDs using extensive mathematical modeling in their research. Carlos Simmerling
                        and Jin Wang in Chemistry are adjunct faculty who work closely with the Applied Math
                        computational biology group. A number of the faculty in the Computational Applied
                        Mathematics group have also worked on problems in biology, involving molecular dynamics,
                        organ modeling, and neural structure.
Evangelos Coutsias' research has focused on the modeling of nonlinear systems and continua, using techniques
                        of applied mathematics on problems motivated from applied physics, engineering and
                        biology. These include asymptotics and perturbation methods for the study of stability
                        and bifurcation phenomena in plasma physics, biology and fluid mechanics; high accuracy
                        numerical spectral methods for solving PDEs arising in continuum mechanics; and robust
                        numerical methods for systems of multivariate polynomials for the solution of problems
                        of inverse kinematics arising in molecular structure studies. His present work is
                        on the development of computational methods for the study of protein structure, especially
                        on the kinematic geometry of protein backbones subject to constraints. Current interests
                        focus on the refinement of protein structure and the development of computational
                        geometric methods for the efficient exploration of macromolecular shapespaces with
                        application to protein design and drug discovery. For more information, see Coutsias webpage.
David Green's research is focused on computational studies of protein interactions. Key areas include:
                        understanding the determinants of specificity in protein interactions through biomolecular
                        simulation; development and application of algorithms for the design of binding interfaces;
                        and development of tools for the study of protein-carbohydrate interactions, with
                        a focus on the glycobiology of HIV-1 infection. His research combines techniques from
                        applied mathematics and models from biophysical chemistry to solve important problems
                        in biology and medicine. For more information, see Green webpage.
Dima Kozakov's research interests lie at the intersection of applied mathematics, physics and computational
                           biology. He focuses on two main goals. The first is the development of mathematically
                           elegant, computationally efficient and physically accurate algorithms for modeling
                           macromolecular structure and function on the genome scale. The second is the application
                           of novel methods to improving the understanding of biological problems and to the
                           design of therapeutic molecules with desired biological and biomedical properties.
                           For more information, see
Kozakov webpage.
Robert Rizzo's research group seeks to understand the atomic basis for molecular recognition for
                        specific biological systems involved in human disease such as HIV/AIDS, cancer, and
                        influenza with the ultimate goal of developing new and improved drugs. Computational
                        methods are used to model how molecules interact at the atomic level with a given
                        drug target. The resultant 3D structural and energetic information is used to quantify
                        and rationalize drug-binding for known systems and to make new predictions. For more
                        information, see Rizzo webpage.
